SFDMY
Shanghai Fudan Microelectronics Co Limited$49.75 +0.00 (+0.00%)
Oct 26 4:00 PM ET · prev $49.75
1 year
0.0%
from $49.75 · Oct 27
30 days
0.0%
from $49.75
52-week range
$49.75–49.75
0% from high · low Oct 27
Avg volume 20D
0
Sep 29 spike 0
Price
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
No data for this timeframe.
- E Sep 8 Trial readout: Results Pending: Budesonide, Formoterol Fumarate, and Umec…
- E Sep 8 Trial readout: Results Pending: MWN109 1 (Phase 2) — Completed 61d ago
- E Sep 8 Trial readout: Results Pending: HRS-9231 Injection (Phase 3) — Completed…
- E Sep 28 Trial readout: T-90d Trial Readout: KN026 (Phase 3)
- E Oct 1 Trial readout: T-90d Trial Readout: SHR-1905 (Phase 2)
- E Oct 5 Trial readout: T-90d Trial Readout: SHR-1905 (Phase 2)
- E Oct 12 Trial readout: Results Pending: Budesonide, Formoterol Fumarate, and Umec…
- E Oct 12 Trial readout: T-90d Trial Readout: A Multicenter, Randomized, Double-bli…
Signal stack
Where each data set points today.
- TrendRANGE
0% above its 50-day average. New closing low $49.75 on Oct 26.
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 12, 2026 Clinical trial readout
Results Pending: Budesonide, Formoterol Fumarate, and Umeclidinium Bromide (Phase 2) — Completed 70d ago
Trial: Efficacy and Safety of CP006 Inhalation Powder in Participants With Asthma Sponsor: Shanghai
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | — | — | — | $0.00 |
| Next Q | — | — | — | $0.00 |
| Current FY | 🔒 Fresh data, subscribers only | |||
| Next FY | — | — | — | $6.6B |
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Oct 12, 2026
Trial readout
Results Pending: Budesonide, Formoterol Fumarate, and Umeclidinium Bromide (Phase 2) — Completed 70d ago
Trial: Efficacy and Safety of CP006 Inhalation Powder in Participants With Asthma Sponsor: Shanghai Xin Huanghe Pharmaceutical Co., Ltd. Phase…
Oct 12, 2026
Trial readout
T-90d Trial Readout: A Multicenter, Randomized, Double-blind, Placebo-c (Phase 2)
Trial: A Multicenter, Randomized, Double-blind, Placebo-controlled Parallel-group Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of…
Oct 7, 2026
Clinical Trial
A Study of the Efficacy and Safety of Carbidopa-Levodopa Extended-Release Tablets in Patients With Parkinson's Disease
Phase 2 · COMPLETED
Oct 5, 2026
Trial readout
T-90d Trial Readout: SHR-1905 (Phase 2)
Trial: A Trial of SHR-1905 in Subjects With Severe Uncontrolled Asthma Sponsor: Shanghai Hengrui Pharmaceutical Co., Ltd. Phase: Phase 2 | Status…
Sep 30, 2026
Trial readout
T-90d Trial Readout: SHR-1905 (Phase 2)
Trial: A Trial of SHR-1905 in Subjects With Severe Uncontrolled Asthma Sponsor: Shanghai Hengrui Pharmaceutical Co., Ltd. Phase: Phase 2 | Status…